While an increase in general well-being and functioning in daily tasks was observed, alterations were not observed in the motor score evaluated via the Unified Parkinson’s disease Rating Scale (UPDRS) or the plasma levels of BDNF and NAA/Cr, as measured via proton magnetic resonance scans (MRI) (Chagas et al., 2014b). This evidence concerns the gene BDNF and Parkinson disease.